Fresh2 Group Ltd (FRES)

Market Cap	9.54M
Revenue (ttm)	2.35M
Net Income (ttm)	-17.21M
Shares Out	124.37M
EPS (ttm)	-3.28
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,311
Open	0.420
Previous Close	0.389
Day's Range	0.377 - 0.400
52-Week Range	0.300 - 9.170
Beta	1.47
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 17, 2024

About FRES

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Jan 30, 2020
• Employees: 75
• Stock Exchange: NASDAQ
• Ticker Symbol: FRES

Financial Performance

In 2022, Fresh2 Group's revenue was 12.04 million, a decrease of -33.04% compared to the previous year's 17.99 million. Losses were -101.89 million, -14.16% less than in 2021.

Financial numbers in CNY